Ticker Symbol: AMLX
Amylyx Pharmaceuticals Inc
Exchange: NASDAQ
Currency:
USD
Asset
Type: Common Stock
CIK:0001658551
Company Profile
Amylyx Pharmaceuticals, Inc is a biopharmaceutical company headquartered in Cambridge, Massachusetts. Amylyx is best known for AMX0035, an experimental therapy for amyotrophic lateral sclerosis.
Sector: Manufacturing
Industry: Medicinal and Botanical Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: N/A
Website: amylyx.com
CEO: N/A
Tags:
N/A
Pricing
Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $16.84
Change:
$0.28
(
1.75%)
Days Range: $16.57 - $17.13
Beta: 0.96
52wk. High: $41.93
52wk. Low: $16.52
Ytd. Change -52.67%
50 Day Moving Average: $18.63
200 Day Moving Average: $23.29
Shares Outstanding: 67377743
Valuation
Market Cap: 113.5B
PE Ratio: -15.31
EPS (TTM): -1.1
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A